Funds affiliated with global investment firm Carlyle have acquired a minority stake in Resonetics, a portfolio company of Sverica Capital Management, valuing the Company at approximately USD2.25 billion.
Sverica initially acquired Resonetics, a specialist in micro-manufacturing for medical devices, in 2014, and then sold a majority interest in the Company in 2018 to private equity firm GTCR. Carlyle will join GTCR as a meaningful shareholder in Resonetics, and Sverica will retain a minority position as a result of the transaction.
